OpenAI cut standard API prices for GPT-5.6 Luna by 80 percent and Terra by 20 percent on July 30, 2026, while leaving Sol unchanged. The company credited lower serving costs and better token-generation efficiency; Chinese vendors are also expanding lower-cost and open-weight alternatives.
Meta announced Muse Glimmer and developer access to Muse Spark 1.2 on August 10, 2026, as CEO Mark Zuckerberg published a 6,500-word case for distributing advanced AI more widely. The release puts Meta’s product strategy behind that argument, but public details do not yet settle access terms, model performance or whether openness reduces risk.
INTERPOL and the United Nations Office on Drugs and Crime warned on March 17, 2026, that generative AI was making trusted-person impersonation easier. A familiar voice or face can now support a false request, so money and data should move only after a separate identity check.
China's internet regulator registered Apple Intelligence for use on iPhones on July 15, 2026, clearing a major barrier to its release in mainland China. The service will draw on AI models from Alibaba and Baidu, but Apple has not announced a launch date.
The US State Department apologized after a presentation at AIDS 2026 displayed a map that misplaced and distorted African countries. The department blamed a last-minute slide change, while a Reuters analysis found a watermark indicating likely use of OpenAI tools.
The US Food and Drug Administration cleared UpDoc on December 23, 2025, as prescription software for adults with type 2 diabetes. Its chat interface collects patient data, while insulin instructions follow clinician-set treatment parameters.
LayerX reported on June 29, 2026, that six agentic browsers and browser plugins copied test SSH credentials after a rigged online game changed the rules they followed. The proof of concept shows how untrusted web content can reach authenticated resources when an agent is allowed to browse and act with a user's access.
A coalition of US state attorneys general reportedly opened an investigation into OpenAI on June 12, 2026, seeking records on advertising, data practices and vulnerable users. The subpoena arrived four days after OpenAI disclosed a confidential draft S-1, but neither the filing nor the subpoena is public.
GPT-5 Pro generated a mechanism for unexplained T-cell data and predicted the direction of an unpublished CAR-T experiment, according to a November 2025 case study. The result shows how a model can help experts form testable hypotheses, but it does not establish autonomous discovery or prove the proposed mechanism.
OpenAI and Molecule.one reported on June 17 that a GPT-5.4 workflow helped identify conditions that improved a difficult Chan-Lam coupling across 10,080 microscale reactions. An automated laboratory supplied the testing capacity, while chemists selected proposals, corrected plans and repeated key experiments by hand.
OpenAI reported in June 2026 that GPT-Rosalind passed 36.1 percent of the 750 tasks in its new LifeSciBench evaluation. Performance fell on tasks involving figures, files or web sources, while the benchmark's design and publication by OpenAI complicate interpretation of its model rankings.
